Exchange: NASDAQ·Updated 07:58 PM EST

About TNXP

About

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
142

Frequently Asked Questions

Advertisement|Remove ads.